Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...

A study shows aggressive lymphomas trigger inflammatory signals that reprogram stromal cells, disrupting lymph node structure ...

Portland scientists at Oregon Health & Science University say they have figured out why pancreatic tumors so often brush off ...

Study also identifies potential path to making immunotherapy effective against the deadly, treatment-resistant cancer Katelyn ...

iACT Stealth is designed to work in tandem with Pluristyx’s FailSafe® technology. FailSafe’s drug-inducible safety feature acts as a genetic “kill switch," allowing for the selective removal of any ...

iACT Stealth is designed to work in tandem with Pluristyx's FailSafe (R) technology. FailSafe's drug-inducible safety feature acts as a genetic "kill switch," allowing for the selective removal of any ...

A new metabolic mechanism describes how tumors disable “gatekeeper” cells to prevent immune response to cancer.

In recent years, CAR T-cell therapy has become a revolutionary, if risky, treatment for some late-stage cancers. Yet CAR T ...

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat.Even with effective antiretroviral therapy, immune ...

MiNK Therapeutics and Memorial Sloan Kettering to present phase II study of agenT-797 combination in PD-1 refractory gastroesophageal cancer at AACR 2026: New York Monday, April 6 ...

The intestinal immune system plays a pivotal role in maintaining mucosal homeostasis, acting as the interface between environmental stimuli, host epithelial ...